93
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Circadian blood pressure abnormalities in patients with primary nephrotic syndrome

, , , , , , , , , & show all
Pages 155-159 | Received 09 Jun 2016, Accepted 28 Aug 2016, Published online: 01 Mar 2017

References

  • Mancia G, Verdecchia P. Clinical value of ambulatory blood pressure: evidence and limits. Circ Res 2015;116:1034–45.
  • Solak Y, Kario K, Covic A,et al. Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension? Clin Exp Nephrol 2016;20:14–22.
  • Pickering TG, Miller NH, Ogedegbe G, et al. American Heart Association; American Society of Hypertension; Preventive Cardiovascular Nurses Association: Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 2008;52:1–9.
  • Imai Y. Clinical significance of home blood pressure and its possible practical application. Clin Exp Nephrol 2014;18:24–40.
  • Boggia J, Li Y, Thijs L, et al. International database on ambulatory blood pressure monitoring in relation to cardiovascular outcomes (IDACO) investigators: prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007;370:1219–29.
  • Fan HQ, Li Y, Thijs L, et al. International database on ambulatory blood pressure in relation to cardiovascular outcomes investigators: prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 2010;28:2036–45.
  • McMullan CJ, Hickson DA, Taylor HA, Forman JP. Prospective analysis of the association of ambulatory blood pressure characteristics with incident chronic kidney disease. J Hypertens 2015;33:1939–46.
  • Gabbai FB, Rahman M, Hu B, et al. African American Study of Kidney Disease and Hypertension (AASK) study group: relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin J Am Soc Nephrol 2012;7:1770–6.
  • Minutolo R, Gabbai FB, Agarwal R, et al. Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. Am J Kidney Dis 2014;64:744–52.
  • Bankir L, Bochud M, Maillard M, et al. Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects. Hypertension 2008;51:891–8.
  • Tsai DH, Riediker M, Wuerzner G, et al. Short-term increase in particulate matter blunts nocturnal blood pressure dipping and daytime urinary sodium excretion. Hypertension 2012;60:1061–9.
  • Kohan DE. Role of collecting duct endothelin in control of renal function and blood pressure. Am J Physiol Regul Integr Comp Physiol 2013;305:R659–68.
  • Covic A, Voroneanu L, Goldsmith D. Routine bioimpedance-derived volume assessment for all hypertensives: a new paradigm. Am J Nephrol 2014;40:434–40.
  • Haruhara K, Tsuboi N, Koike K, et al. Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients. Hypertens Res 2015;38:116–22.
  • Haruhara K, Tsuboi N, Koike K, et al. Ambulatory blood pressure and tubulointerstitial injury in patients with IgA nephropathy. Clin Kidney J 2015;8:716–21.
  • Küster S, Mehls O, Seidel C, Ritz E. Blood pressure in minimal change and other types of nephrotic syndrome. Am J Nephrol 1990;10 Suppl 1:76–80.
  • Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int 2012;82:635–42.
  • Svenningsen P, Friis UG, Versland JB,et al. Mechanisms of renal NaCl retention in proteinuric disease. Acta Physiol 2013;207:536–45.
  • Cadnapaphornchai MA, Tkachenko O, Shchekochikhin D, Schrier RW. The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications. Pediatr Nephrol 2014;29:1159–67.
  • Koopman MG, Koomen GC, van Acker BA, Arisz L. Urinary sodium excretion in patients with nephrotic syndrome, and its circadian variation. Q J Med 1994;87:109–17.
  • Barenbrock M, Spieker C, Hausberg M, et al. Studies on diurnal blood pressure variation in kidney diseases associated with excessive salt and water retention. J Hum Hypertens 1999;13:269–73.
  • Andoh D, Kobayashi M, Yasuda G, et al. Loss of nocturnal decline of blood pressure in non-diabetic patients with nephrotic syndrome in the early and middle stages of chronic kidney disease. Hypertens Res 2009;32:364–8.
  • Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159–219.
  • Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982–92.
  • Imai Y, Abe K, Sasaki S, et al. Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations. J Hypertens 1989;7:113–20.
  • Ivy JR, Oosthuyzen W, Peltz TS, et al. Glucocorticoids induce nondipping blood pressure by activating the thiazide-sensitive cotransporter. Hypertension 2016;67:1029–37.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.